Podcast
Two Onc Docs
Hosted by Sam and Karine · EN
This is Sam and Karine, and we are Two Onc Docs! We both graduated from our Heme/Onc fellowships in 2021 and became board certified in both Hematology and Oncology. Our mission with Two Onc Docs is to create short board review episodes that you can listen to on your drive to work, while you make your morning coffee, or between pages on call. This is intended to be a supplement to other established board studying resources for busy trainees. *This podcast is intended to be an educational resource for health care providers.*
43episodes
Episodes
Newest firstAll episodes
Aplastic Anemia 2026 UPDATE
May 1100:11:30Tap to summarizeToday’s episode is focusing on the highest yield facts about Aplastic Anemia. This will include the mechanism of AA, diagnostic work-up, treatment of AA, and the evolution of clones including PNH.
Transcribe →Metastatic Bladder Cancer 2026 UPDATE
May 400:09:20Tap to summarizeToday’s episode is focusing on what you need to know regarding metastatic bladder cancer, with 2026 updates. This will include the need to know treatment options and toxicities for metastatic urothelial carcinoma, and also discuss the management of upper tract + variant non-urothelial histology.
Transcribe →Localized Bladder Cancer 2026 UPDATE
Apr 2700:13:21Tap to summarizeToday’s episode is focusing on what you need to know regarding localized bladder cancer, with 2026 updates. This will include the need to know pathology, presentation, diagnostic work-up, staging, and treatment options.
Transcribe →4 Years with Two Onc Docs
Apr 2000:12:00Tap to summarizeThis week’s episode will be focusing on how we met, the future of the podcast, and why we picked heme/onc. This is a very different style of episode and a special once because this month is our 4 year anniversary of Two Onc Docs! And we will back to our regular programming next week with overdue updates on Bladder Cancer.
Transcribe →Pancreatic Cancer x Dr. Michael Pishvaian 2026 UPDATE Part 3
Apr 1300:14:01Tap to summarizeWe are back with a very special guest Dr. Michael Pishvaian, who is an Associate Professor in GI Oncology at the Johns Hopkins Kimmel Cancer Center, and creator of Tumor Board Tuesday. In part 3, we discuss supportive care in pancreatic cancer, and exciting trials in this space.
Transcribe →Metastatic Pancreatic Cancer x Dr. Michael Pishvaian 2026 UPDATE Part 2
Apr 600:25:07Tap to summarizeWe are back with a very special guest Dr. Michael Pishvaian, who is an Associate Professor in GI Oncology at the Johns Hopkins Kimmel Cancer Center, and creator of Tumor Board Tuesday. In part 2, we will focus on metastatic pancreatic cancer, 1L treatments, maintenance therapy, targeted therapy + more.
Transcribe →Localized Pancreatic Cancer x Dr. Michael Pishvaian 2026 UPDATE Part 1
Mar 3000:37:00Tap to summarizeThis week’s episode will be discussing Pancreatic Cancer with a very special guest Dr. Michael Pishvaian. Dr. Pishvaian is an Associate Professor in GI Oncology at the Johns Hopkins Kimmel Cancer Center, and creator of Tumor Board Tuesday. In part 1, we will focus on risk factors, diagnosis and treatment of localized pancreatic cancer.
Transcribe →ASCO GU 2026 Takeaways
Mar 2300:12:09Tap to summarizeThis week’s episode will be focusing on a recap of some of the important data ASCO GU just held in San Francisco end of February. We will go over some topics in prostate, RCC, bladder cancer, and other GU tumors.
Transcribe →Neuroendocrine Tumors 2026 UPDATE
Mar 1600:23:35Tap to summarizeThis week’s episode will be focusing on Neuroendocrine Tumors (NET). We will go over all the important details regarding the heterogeneous group of NETs, diagnosis, work-up, treatment, and focus mostly on gastro-entero-pancreatic NETs.
Transcribe →Venous Thromboembolism (VTE) in Cancer Part 2
Mar 900:14:24Tap to summarizeThis week’s episode we are back with our special guest & thrombosis expert Dr. Marc Carrier. In part 2, we discuss additional special considerations like IVC filter indications, and management of VTEs in the setting of thrombocytopenia. We also discuss VTE prevention in patients with cancer, the Khorana score, exciting research to come in this space, and career advice.
Transcribe →